Vesatolimod Pharmacodynamic Responses in a Trial of Vesatolimod and Broadly Neutralizing Antibodies in Early-Treated South African Women With Clade C HIV-1

Conference Reports for NATAP

IAS 2025, 13th IAS Conference on HIV Science
Kigali, Rwanda
July 13-17


Vesatolimod Pharmacodynamic Responses in a Trial of Vesatolimod and Broadly Neutralizing Antibodies in Early-Treated South African Women With Clade C HIV-1

	13th IAS Conference on HIV Science; July 13–17, 2025; Kigali, Rwanda Yanhui Cai1*,